Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Caractérisation semi-automatique De MD-L1 et…
JoVE Journal
Cancer Research

A subscription to JoVE is required to view this content.

JoVE Journal Cancer Research
Caractérisation semi-automatique De MD-L1 et recensement des cellules tumorales circulantes de patients atteints d'immunofluorescence
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Journal (Cancer Research)
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research
Journal (Cancer Research)
Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research
 
Click here for the English version

Caractérisation semi-automatique De MD-L1 et recensement des cellules tumorales circulantes de patients atteints d'immunofluorescence

Article DOI: 10.3791/59873-v • 10:29 min • August 14th, 2019
August 14th, 2019 •
1,2,3, 1,2,3, 1,2, 1,2,3, 4, 4, 5, 1, 3, 6,7, 1,2,3
1Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 2Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon Cancer Institute, 3University of Lyon, Claude Bernard University, Cancer Research Center of Lyon, 4Biolidics Limited, 5Institut de Pathologie Multisites des HCL-Site Sud, Hospices Civils de Lyon, 6Acute Respiratory Disease and Thoracic Oncology Department, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, 7EMR-3738 Therapeutic Targeting in Oncology, Lyon Sud Medical Faculty, Lyon 1 University

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

La caractérisation des cellules tumorales circulantes (CTC) est un sujet populaire dans la recherche translationnelle. Ce protocole décrit un test semi-automatique d'immunofluorescence (IF) pour la caractérisation de PD-L1 et l'énumération des CTC dans les échantillons patients de cancer de poumon de non-petite cellule (NSCLC).

Tags

Recherche sur le cancer numéro 150 cancer du poumon cellules tumorales circulantes analyse libre de circulation analyse d'immunofluorescence CTC dispositif microfluidique en spirale PD-L1
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter